Efficacy and safety of endostar in the treatment of advanced lung squamous cell carcinoma.

被引：0
|
作者：
Hu, Weiheng
Fang, Jian
Nie, Jun
Dai, Ling
Zhang, Jie
Chen, Xiaoling
Ma, Xiangjuan
Tan, Guangming
Wu, Di
Han, Jindi
Han, Sen
Wang, Yang
Long, Jieran
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e20574
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20574
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma
    Guofu Chen
    Liming Sheng
    Xianghui Du
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 505 - 510
  • [42] A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma.
    Oya, Mototsugu
    Tamada, Satoshi
    Tatsugami, Katsunori
    Nakaigawa, Noboru
    Osawa, Takahiro
    Kanayama, Hiro-Omi
    Kondoh, Chihiro
    Sassa, Naoto
    Nishimura, Kazuo
    Nozawa, Masahiro
    Masumori, Naoya
    Miyoshi, Yasuhide
    Kimura, Akiko
    Kuroda, Shingo
    Motzer, Robert J.
    Choueiri, Toni K.
    Tomita, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Gastric squamous cell carcinoma.
    Penaranda, JMS
    Santias, RMR
    Baltar, J
    Vila, JF
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (05) : 369 - 371
  • [44] Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.
    Li, Jieying
    Song, Kai
    Feng, Yuanyong
    Shang, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18001 - E18001
  • [45] Efficacy and outcome analysis: Combination of Endostar and chemotherapy as a neoadjuvant treatment of stage IIIA/IIIB squamous cell lung cancer
    Cao, Feiyi
    Ding, Sijie
    Gu, Cuiping
    Zhou, Yao
    Hong, Wei
    Jin, Ying
    ONCOLOGY LETTERS, 2024, 27 (01)
  • [46] Immune heterogeneity in adenocarcinoma and squamous cell carcinoma components of lung adenosquamous carcinoma.
    Lin, Gen
    Li, Chao
    Li, Pansong
    Fang, Wenzheng
    Xu, Hai-Peng
    Lv, Xinze
    Li, Qian
    Xia, Xuefeng
    Miao, Qian
    Wu, Biao
    Jiang, Kan
    Zheng, Xiaobin
    Huang, Cheng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Efficacy and safety of low-dose apatinib in advanced hepatocellular carcinoma.
    Meng, Lingbin
    Zheng, Zhuangzhuang
    Ji, Rui
    Xu, Xiaochun
    Xin, Ying
    Jiang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma
    Collier, Nicholas J.
    Ali, Faisal R.
    Lear, John T.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (10) : 1011 - 1018
  • [49] Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma
    Gunnarsson, Orvar
    Pfanzelter, Nicklas R.
    Cohen, Roger B.
    Keefe, Stephen M.
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 65 - 73
  • [50] Multimodality approach towards advanced rectal carcinoma. "Its efficacy and safety"
    Lygidakis, NJ
    Safioleas, M
    HEPATO-GASTROENTEROLOGY, 2005, 52 (62) : 385 - 390
12345